← Evidence library

BIB_406

🟢 Aebischer/Leiter 2025 (German Central Malignant Melanoma Registry, n=12,132) — the empirical hazard-rate-by-thickness-band evidence that ANCHORS this exact-0.8 mm patient to the INTENSIVE Stage IB follow-up cadence. Fills a real gap: the brief's surveillance schedule rested on guideline sources (BIB244 WoSCAN, SIGN 146) with no patient-band-specific recurrence-hazard data. KEY: melanomas of 0.8–1.0 mm behave like Stage IB (9.8% recurrence; 10-yr RFS 81.9%; peak yearly hazard up to 1:313 in years 1–5) — materially worse than <0.8 mm (3.7% recurrence; 10-yr RFS 91.5%; ≤1:1111/yr) — so this pa…

Evidence grade

A

Tier

1 (EJC Skin Cancer — peer-reviewed; very lar

Cited by tasks

5, 7, 24, 25

Identifiers

DOI:10.1016/j

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_406/findings.md (research corpus). This page is a short context summary — not individualised medical advice.